|
PGAM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.794100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.855100E-03 |
| Normal-vs-Stage2 |
6.344300E-02 |
| Normal-vs-Stage3 |
3.038300E-02 |
| Normal-vs-Stage4 |
1.708200E-02 |
| Stage1-vs-Stage2 |
3.746000E-01 |
| Stage1-vs-Stage3 |
4.906400E-01 |
| Stage1-vs-Stage4 |
8.345600E-02 |
| Stage2-vs-Stage3 |
6.653800E-01 |
| Stage2-vs-Stage4 |
6.166200E-01 |
| Stage3-vs-Stage4 |
2.849000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.969100E-04 |
| Normal-vs-AfricanAmerican |
6.095900E-03 |
| Normal-vs-Asian |
3.750400E-01 |
| Caucasian-vs-AfricanAmerican |
8.387400E-01 |
| Caucasian-vs-Asian |
9.171400E-01 |
| AfricanAmerican-vs-Asian |
9.735400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.740200E-03 |
| Normal-vs-Female |
5.7266999999972E-05 |
| Male-vs-Female |
1.509690E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.521500E-02 |
| Normal-vs-Extreme_Weight |
6.224200E-02 |
| Normal-vs-Obese |
1.420570E-03 |
| Normal-vs-Extreme_Obese |
2.914400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.080200E-01 |
| Normal_Weight-vs-Obese |
5.249400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.214000E-01 |
| Extreme_Weight-vs-Obese |
2.600800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.966000E-01 |
| Obese-vs-Extreme_Obese |
8.975800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.799200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.675270E-03 |
| Normal-vs-Age(61-80Yrs) |
6.774000E-04 |
| Normal-vs-Age(81-100Yrs) |
3.627400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.896200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.497000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.259000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.072600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.973600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.551000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.245820E-02 |
| Normal-VS-Type2 PRCC |
5.639200E-04 |
| Normal-VS-KIRP CIMP |
3.759600E-01 |
| Normal-VS-Unclassified PRCC |
2.321700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.110200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.589400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.456400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.029800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.928400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.340400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.135890E-02 |
| Normal-vs-N1 |
4.969400E-01 |
| Normal-vs-N2 |
7.272100E-02 |
| N0-vs-N1 |
1.845580E-01 |
| N0-vs-N2 |
9.930400E-01 |
| N1-vs-N2 |
4.091800E-01 |
|
|
